Related Experiment Video
Updated: May 16, 2025
Author Spotlight: Insights into the Techniques and Findings of Recent Advancements in Epilepsy Research
Published on: October 13, 2023
Protective effect of CACNA1A deficiency in oligogenic refractory epilepsy with CACNA1A-CELSR2 digenic mutations
Chu-Qiao Liu1, Mei-Zhen Sun2, Yong-Miao Lin1
1Department of Neurology, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Objective:
The vast majority of refractory epilepsy cases have a complex oligogenic/polygenic origin, which presents a challenge to precision medicine in individual patients. Nonetheless, the high workload and lack of effective guidelines have limited the number of in-depth animal studies.
Methods:
Whole-exon sequencing identified a case with refractory epilepsy caused by a combination of two rare and de novo heterozygous variants in CACNA1A and CELSR2, respectively. Polygenic mutation flies were established and logistic regression were applied to study the gene-gene interaction and quantify the seizure-risk weight of epilepsy-associated genes in a polygenic background. In addition, calcium imaging, pharmacology, and transgenic rescue experiments were used to explore the mechanism and the precision medicine strategy for this model.
Results:
Seizure-like activity was mitigated in the Cacna1a-Celsr2 digenic knockdown flies, whereas it was aggravated in the Cacna1a knockin-Celsr2 knockdown flies, and all relevant monogenic mutation flies showed seizures. Logistic regression suggested that the Cacna1a deficiency provided a protective effect against seizures in Celsr2 knockdown flies. The severe seizures from Cacna1a knockin-Celsr2 knockdown, the genotype mimicking that of the patient, can be completely rescued by inhibiting the calcium channel via genetic (Cacna1a knockdown) or pharmacologic (pregabalin) treatment during a limited period of development. Calcium imaging results suggested a synaptic cleft balance mechanism for the protective effect of CACNA1A deficiency in the polygenic background.
Significance:
CACNA1A presented multiple effects on epileptogenesis in diverse genetic backgrounds and provided an effective preclinical approach to clarify the net impact of polygenic variants for designing a precisive medicine strategy against refractory epilepsy.
Insights
Refractory epilepsy with multiple gene variants can be treated. Targeting calcium channels with drugs like pregabalin offers a precision medicine approach for complex genetic epilepsy cases.
Area of Science:
- Neurogenetics
- Epilepsy Research
- Precision Medicine
Background:
- Refractory epilepsy often stems from complex genetic origins, complicating personalized treatment strategies.
- Limited animal studies hinder understanding of polygenic epilepsy and development of effective interventions.
Purpose of the Study:
- To investigate a refractory epilepsy case caused by combined de novo variants in CACNA1A and CELSR2.
- To explore gene-gene interactions and develop precision medicine strategies for polygenic epilepsy.
Main Methods:
- Whole-exon sequencing to identify genetic variants.
- Establishing polygenic mutation fly models.
- Employing logistic regression, calcium imaging, pharmacology, and transgenic rescue experiments.
Main Results:
- Digenic knockdown of Cacna1a and Celsr2 mitigated seizure-like activity in flies.
- Knockin of Cacna1a with Celsr2 knockdown mimicked patient genotype and caused severe seizures.
- Genetic or pharmacologic inhibition of calcium channels (e.g., pregabalin) rescued seizures in the model.
Conclusions:
- CACNA1A influences epileptogenesis across different genetic backgrounds.
- This study provides a preclinical model to understand polygenic variant impact for precision epilepsy medicine.
